Describes Antisense Oligonucleotide (ASO) technology and how it can be used to treat a variety of genetic disorders with no previous effective conventional therapy. Spinal Muscular Atrophy (SMA) and Lipoprotein (a) or Lp(a) are presented as examples.
12 окт 2022
